GOODMAN JESSE 4
4 · Intellia Therapeutics, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
GOODMAN JESSE
Director
Transactions
- Sale
Common Stock
2025-07-01$9.23/sh−1,547$14,279→ 24,359 total - Sale
Common Stock
2025-06-30$9.56/sh−1,547$14,789→ 25,906 total
Footnotes (1)
- [F1]The reported sale of 3,094 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 31, 2025.